Eur Rev Med Pharmacol Sci 2022; 26 (21): 7732-7732
DOI: 10.26355/eurrev_202211_30119

Retraction Note: Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2

Y. Yin, Z.-F. Yang, X.-H. Li, L.-Q. Zhou, Y.-J. Zhang, B. Yang

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China


The article “Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2, by Y. Yin, Z.-F. Yang, X.-H. Li, L.-Q. Zhou, Y.-J. Zhang, B. Yang, published in Eur Rev Med Pharmacol Sci 2019; 23 (19): 8560-8565–DOI: 10.26355/eurrev_201910_19171–PMID: 31646588” has been retracted by the authors as they cannot ensure the reproducibility of the data. The third party who provided some data turned out to be unreliable.

The same manuscript was also questioned on PubPeer after publication.

 

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2

Free PDF Download

To cite this article

Y. Yin, Z.-F. Yang, X.-H. Li, L.-Q. Zhou, Y.-J. Zhang, B. Yang
Retraction Note: Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 21
Pages: 7732-7732
DOI: 10.26355/eurrev_202211_30119